Concepedia

MicroRNA-10b Expression Correlates with Response to Neoadjuvant Therapy and Survival in Pancreatic Ductal Adenocarcinoma

Meir Preis, Timothy B. Gardner, Stuart R. Gordon, J. Marc Pipas, Todd A. MacKenzie, Erin E. Klein, Daniel S. Longnecker, Edward J. Gutmann, Lorenzo F. Sempere, Murray Korc

Clinical Cancer Research · 2011 · 157 citations · 34 references

DOIFull text

Open access

Abstract

miR-10b is a novel diagnostic biomarker for PDACs when assessing pancreatic lesions. Expression of miR-10b is predictive of response to neoadjuvant therapy and outcome in this disease.

References

34

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 28.6K citations

, , +9

Prospective identification of tumorigenic breast cancer cells

Muhammad Al‐Hajj, Max S. Wicha, Adalberto Benito‐Hernández et al. · Proceedings of the National Academy of Sciences · 2003 · 10.3K citations · Full text

Tumour invasion and metastasis initiated by microRNA-10b in breast cancer

Li Ma, Julie Teruya‐Feldstein, Robert A. Weinberg · Nature · 2007 · 2.6K citations

, , +9

ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer

Gershon Y. Locker, Stanley R. Hamilton, Jules E. Harris et al. · Journal of Clinical Oncology · 2006 · 1.6K citations

MicroRNA Expression Patterns to Differentiate Pancreatic Adenocarcinoma From Normal Pancreas and Chronic Pancreatitis

Mark Bloomston, Wendy L. Frankel, Fabio Petrocca et al. · JAMA · 2007 · 1.1K citations